MAPT and Alzheimer disease: The triple-transgenic model of AD (3xTg-AD) displays Aβ plaques, tau-laden neurofibrillary tangles, and age-dependent alterations in memory function and was developed to investigate both canonical markers of AD neuropathology in the same animal [13–16].